Glycemic Variability Is Associated with Markers of Vascular Stress in Adolescents - 25/04/16

Abstract |
Objectives |
We used continuous glucose monitoring to test the hypothesis that mean amplitude of glycemic excursions (MAGE) is associated with circulating markers of oxidative and vascular stress in adolescents with habitually low physical activity classified as healthy weight, healthy obese, or obese with type 2 diabetes mellitus (T2DM).
Study design |
A group of 13- to 21-year-olds (healthy weight = 12, healthy obese = 10, T2DM = 12) wore a continuous glucose monitor and step activity monitor for 5 days.
Results |
Physical activity was similar among groups (6551 ± 401 steps/d), but aerobic fitness (peak rate of oxygen consumption) was lower (P < .05) in T2DM (15.6 ± 1.8 mL/kg/min) than either healthy weight (26.2 ± 2.2) or healthy obese (24.4 ± 2.5). MAGE (mg/dL) was higher (P < .01) in T2DM (82 ± 10) vs healthy obese (33 ± 3) and healthy weight (30 ± 3). Average glucose followed a similar pattern as MAGE. Oxidized low density lipoprotein was higher (P < .05) in T2DM (70.3 ± 5.0 U/L) and healthy obese (58.1 ± 3.8) than healthy weight (48.4 ± 2) and positively correlated with MAGE (r = 0.77). Other stress markers that were both elevated in T2DM and correlated with MAGE included E-selectin (r = 0.50), intercellular adhesion molecule 1 (r = 0.35), and C-reactive protein (r = 0.52); soluble receptor for advanced glycosylation end product was lower in T2DM and inversely correlated with MAGE (r = −0.38).
Conclusions |
MAGE is highest in obese youth with T2DM. The associations between MAGE and oxidative stress markers support the proposed contribution of glycemic variability to risk for future cardiovascular disease.
Le texte complet de cet article est disponible en PDF.Abbreviations : AUC, BMI, CGM, CRP, HbA1c, HDL-C, ICAM-1, iHOMA2, LDL-C, MAGE, NEFA, OGTT, oxLDL, sRAGE, T2DM, VCAM-1, VO2peak
Plan
| Funded by the University of Oklahoma Health Sciences Center Department of Pediatrics (SL Young Fellowship Award to P.D.). Study supplies were provided by Medtronic MiniMed, Inc (Northridge, CA), and Contour–Bayer, neither of which had any input about the study design or data analyses. The authors declare no conflicts of interest. |
Vol 172
P. 47 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
